Skip to main content

Table 4 Statistical analysis of data from Fig. 1

From: Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand’s COOL-AF registry

  Gr 1 versus Gr 2
(p-value)
Gr 1 versus Gr 6
(p-value)
Gr 3 versus Gr 4
(p-value)
Gr 3 versus Gr 6
(p-value)
Gr 4 versus Gr 6
(p-value)
Gr 5 versus Gr 6
(p-value)
Rate of OAC 84.3 vs. 76.0
 < 0.001
84.3 vs. 76.4
0.009
65.9 vs. 79.6
0.065
65.9 vs. 76.4
0.168
79.6 vs. 76.4
0.494
68.3 vs. 76.4
0.286
No OAC
 No AP 22.3 vs. 6.2
 < 0.001
22.3 vs. 10.5
0.092
7.1 vs. 6.5
0.931
7.1 vs. 10.5
0.714
6.5 vs. 10.5
0.684
–-
 1 AP 72.3 vs. 63.6
 < 0.001
72.3 vs. 81.6
0.223
–- –- 71.0 vs. 81.6
0.299
38.5 vs. 81.6
0.011
 2 AP 5.0 vs. 30.2
 < 0.001
5.0 vs. 7.9
0.441
92.9 vs. 22.6
 < 0.001
92.9 vs. 7.9
 < 0.001
22.6 vs. 7.9
0.100
61.5 vs. 7.9
 < 0.001
Taking OAC
 No AP 94.1 vs. 54.4
 < 0.001
94.1 vs. 77.2
 < 0.001
11.1 vs. 33.1
0.023
11.1 vs. 77.2
 < 0.001
33.1 vs. 77.2
 < 0.001
67.9 vs. 77.2
0.298
 1 AP 5.5 vs. 37.5
 < 0.001
5.5 vs. 20.3
 < 0.001
25.9 vs. 59.5
0.002
25.9 vs. 20.3
0.520
59.5 vs. 20.3
 < 0.001
28.6 vs. 20.3
0.341
 2 AP 0.3 vs. 8.1
 < 0.001
0.3 vs. 4.3
0.013
63.0 vs. 7.4
 < 0.001
63.0 vs. 4.3
 < 0.001
7.4 vs. 4.3
0.071
3.6 vs. 4.3
0.564
  1. A p-value < 0.05 indicates statistical significance
  2. OAC, oral anticoagulant; AP, antiplatelet
  3. Group 1 = patients without history of coronary artery disease
  4. Group 2 = patients with history of coronary artery disease (overall)
  5. Group 3 = patients who underwent percutaneous coronary intervention with drug-eluting stent within 1 year
  6. Group 4 = patients who underwent percutaneous coronary intervention with stent longer than 1 year
  7. Group 5 = patients who experienced acute coronary syndrome without receiving a stent
  8. Group 6 = patients with coronary artery disease without history of acute coronary syndrome or receiving a stent